Search Results - Bart Luijk

  • Showing 1 - 3 results of 3
Refine Results
  1. 1

    Clara cell 16 kDa protein: an important marker for COVID-19 severity by Tineke Kardol-Hoefnagel, Bart Luijk, Leon Reteig, Saskia Haitjema, Helen L. Leavis, Henny G. Otten, Henny G. Otten

    Published in Frontiers in Immunology (2025-04-01)
    Get full text
    Article


  2. 2

    Mitigating the risk of inflammatory type primary graft dysfunction by applying an integrated approach to assess, modify and match risk factors in lung transplantation by Sue A. Braithwaite, Elize M. Berg, Linda M. de Heer, Jitte Jennekens, Arne Neyrinck, Elise van Hooijdonk, Bart Luijk, Wolfgang F. F. A. Buhre, Niels P. van der Kaaij

    Published in Frontiers in Transplantation (2024-08-01)
    Get full text
    Article


  3. 3

    Evaluation of Elexacafor/Tezacaftor/Ivacaftor therapy after lung transplantation in Cystic Fibrosis: The Dutch National KOALA study by Johanna P. van Gemert, Bart Luijk, Merel E. Hellemons, Klara A. Visser, Carina.M.E. Hansen, Renske van der Meer, C. Tji Gan, Hester van der Vaart, Onno W. Akkerman, Willie N. Steenhuis, Marieke Verkleij, Harry G.M. Heijerman, Erik A.M. Verschuuren

    Published in JHLT Open (2025-02-01)
    Get full text
    Article


Search Tools: